Impact Factor 4.137 | CiteScore 4.28
More on impact ›
This section of Frontiers in Oncology aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.
We welcome contributions from the basic and translational neurosciences, in addition to research derived from clinical studies and prospective trials. Our focus extends beyond primary brain tumors to include brain and CNS metastases, as well as benign and skull-based tumors. Our audience centers on the many disciplines involved in brain tumor research: clinical neuro-oncology, neurosurgical oncology, radiation oncology, neuropathology and neuroradiology.
All submissions are expected to advance both our understanding of brain tumor biology and the efforts of clinicians and surgeons treating these patients around the world.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Neuro-Oncology and Neurosurgical Oncology welcomes submissions of the following article types: Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Neuro-Oncology and Neurosurgical Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Neuro-Oncology and Neurosurgical Oncology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Neurology and Oncology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org